Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer

American Family Physician

Volumn 79, Issue 4, 2009, Pages 325-326

  Lin, Kenneth W ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER SCREENING; CARDIOVASCULAR DISEASE; CASE REPORT; COLORECTAL CANCER; HEART INFARCTION; HUMAN; MALE; PHYSICAL EXAMINATION; ASIAN; COLORECTAL TUMOR; GENETIC PREDISPOSITION; INCIDENCE; MIDDLE AGED; RISK FACTOR; STATISTICS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASIAN CONTINENTAL ANCESTRY GROUP; ASPIRIN; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS;

EID: 63249087174     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. U.S. Preventive Services Task Force. Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007;146(5):361-364. (Pubitemid 351650596)
2. Dubé C, Rostom A, Lewin G, et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med. 2007;146(5):365-375. (Pubitemid 351650597)
3. Rostom A, Dubé C, Lewin G, et al., for the University of Ottawa Evidence-based Practice Center. Use of aspirin and NSAIDs to prevent colorectal cancer. Rockville, Md.: Agency for Healthcare Research and Quality; 2007.